Notable Labs — Company Overview, News & Financial Data
Notable Labs develops predictive precision medicines for cancer treatment, aiming to accelerate drug development and meet unmet needs.
Notable Labs
About
Notable Labs (NASDAQ:NTBL) is a clinical-stage biotech company on the NASDAQ exchange. They develop "predictive precision medicines" for cancer patients. Their core technology, the Predictive Precision Medicines Platform (PPMP), uses bio-simulation to predict a patient's response to treatment before it's administered. This aims to identify ideal candidates and accelerate drug development. Notable Labs focuses on unmet medical needs in cancer treatment, with Volasertib, a drug for acute myeloid leukemia, as their lead program. Their stock price is currently $0.99.
Snapshot
Operations
Products and/or services of Notable Labs
- Predictive Precision Medicines Platform (PPMP): This is their core technology, a platform that uses bio-simulation to predict patient response to cancer treatment.
- Predictive Precision Medicines Development: They leverage PPMP to develop new, targeted cancer drugs.
- Clinical Trial Design & Patient Selection: Notable Labs might design clinical trials for their drugs and use PPMP to select ideal participants.
- Partnerships for Drug Development & Commercialization: They could potentially partner with other companies to develop and sell their predicted precision medicines.
- Licensing of PPMP Technology: There's a possibility they might license their PPMP technology to other institutions in the future.
- Cancer Research & Collaboration: Notable Labs likely collaborates with research institutions to further develop cancer treatments.
Notable Labs executive team
- Mr. Scott Alan McPherson CFE, CPA, CVAChief Financial Officer
- Dr. Joseph P. Wagner Ph.D.Chief Scientific Officer
- Ms. Kaile ZaggerInterim CEO & Chief Restructuring Officer
- Dr. Glenn C. Michelson M.D.Chief Medical Officer
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift